156 related articles for article (PubMed ID: 24711674)
1. Calcium channel autoantibodies predicted sudden cardiac death and all-cause mortality in patients with ischemic and nonischemic chronic heart failure.
Yu H; Pei J; Liu X; Chen J; Li X; Zhang Y; Li N; Wang Z; Zhang P; Cao K; Pu J
Dis Markers; 2014; 2014():796075. PubMed ID: 24711674
[TBL] [Abstract][Full Text] [Related]
2. The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure.
Pei J; Li N; Chen J; Li X; Zhang Y; Wang Z; Zhang P; Cao K; Pu J
Eur J Heart Fail; 2012 Aug; 14(8):887-94. PubMed ID: 22713286
[TBL] [Abstract][Full Text] [Related]
3. The J wave and fragmented QRS complexes in inferior leads associated with sudden cardiac death in patients with chronic heart failure.
Pei J; Li N; Gao Y; Wang Z; Li X; Zhang Y; Chen J; Zhang P; Cao K; Pu J
Europace; 2012 Aug; 14(8):1180-7. PubMed ID: 22308082
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China.
Liu X; Yu H; Pei J; Chu J; Pu J; Zhang S
Heart Lung Circ; 2014 Sep; 23(9):818-26. PubMed ID: 24881031
[TBL] [Abstract][Full Text] [Related]
5. Agonist-like autoantibodies against calcium channel in patients with dilated cardiomyopathy.
Xiao H; Wang M; Du Y; Yuan J; Zhao G; Tu D; Liao YH
Heart Vessels; 2012 Sep; 27(5):486-92. PubMed ID: 21814855
[TBL] [Abstract][Full Text] [Related]
6. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
[TBL] [Abstract][Full Text] [Related]
7. Arrhythmogenic autoantibodies against calcium channel lead to sudden death in idiopathic dilated cardiomyopathy.
Xiao H; Wang M; Du Y; Yuan J; Cheng X; Chen Z; Zou A; Wei F; Zhao G; Liao YH
Eur J Heart Fail; 2011 Mar; 13(3):264-70. PubMed ID: 21044990
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma levels of asymmetric dimethylarginine and the risk for arrhythmic death in ischemic and non-ischemic, dilated cardiomyopathy - A prospective, controlled long-term study.
Burger AL; Stojkovic S; Diedrich A; Demyanets S; Wojta J; Pezawas T
Clin Biochem; 2020 Sep; 83():37-42. PubMed ID: 32504703
[TBL] [Abstract][Full Text] [Related]
9. Common Variants in TRDN and CALM1 Are Associated with Risk of Sudden Cardiac Death in Chronic Heart Failure Patients in Chinese Han Population.
Liu Z; Liu X; Yu H; Pei J; Zhang Y; Gong J; Pu J
PLoS One; 2015; 10(7):e0132459. PubMed ID: 26196381
[TBL] [Abstract][Full Text] [Related]
10. Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy.
Doesch AO; Mueller S; Nelles M; Konstandin M; Celik S; Frankenstein L; Goeser S; Kaya Z; Koch A; Zugck C; Katus HA
Basic Res Cardiol; 2011 Jan; 106(1):25-35. PubMed ID: 20957484
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.
Müller FS; Aherrahrou Z; Grasshoff H; Heidorn MW; Humrich JY; Johanson L; Aherrahrou R; Reinberger T; Schulz A; Ten Cate V; Robles AP; Koeck T; Rapp S; Lange T; Brachaczek L; Luebber F; Erdmann J; Heidecke H; Schulze-Forster K; Dechend R; Lackner KJ; Pfeiffer N; Ghaemi Kerahrodi J; Tüscher O; Schwarting A; Strauch K; Münzel T; Prochaska JH; Riemekasten G; Wild PS
Eur Heart J; 2023 Dec; 44(47):4935-4949. PubMed ID: 37941454
[TBL] [Abstract][Full Text] [Related]
12. N8-Acetylspermidine: A Polyamine Biomarker in Ischemic Cardiomyopathy With Reduced Ejection Fraction.
Nayak A; Liu C; Mehta A; Ko YA; Tahhan AS; Dhindsa DS; Uppal K; Jones DP; Butler J; Morris AA; Quyyumi AA
J Am Heart Assoc; 2020 Jun; 9(11):e016055. PubMed ID: 32458724
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function.
Michelucci A; D'Elios MM; Sticchi E; Pieragnoli P; Ricciardi G; Fatini C; Benagiano M; Niccolai E; Grassi A; Attanà P; Nesti M; Grifoni G; Padeletti L; Abbate R; Prisco D
Pacing Clin Electrophysiol; 2016 Jan; 39(1):65-72. PubMed ID: 26411359
[TBL] [Abstract][Full Text] [Related]
14. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study.
Olshansky B; Poole JE; Johnson G; Anderson J; Hellkamp AS; Packer D; Mark DB; Lee KL; Bardy GH;
J Am Coll Cardiol; 2008 Apr; 51(13):1277-82. PubMed ID: 18371559
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy.
Leyva F; Taylor RJ; Foley PW; Umar F; Mulligan LJ; Patel K; Stegemann B; Haddad T; Smith RE; Prasad SK
J Am Coll Cardiol; 2012 Oct; 60(17):1659-67. PubMed ID: 23021326
[TBL] [Abstract][Full Text] [Related]
16. Circulating miR-192 is a prognostic marker in patients with ischemic cardiomyopathy.
Klenke S; Eul S; Peters J; Neumann T; Adamzik M; Frey UH
Future Cardiol; 2018 Jul; 14(4):283-289. PubMed ID: 29927310
[TBL] [Abstract][Full Text] [Related]
17. Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.
Briongos-Figuero S; Estévez A; Luisa Pérez M; Martínez-Ferrer JB; García E; Viñolas X; Arenal Á; Alzueta J; Basterra N; Rodríguez A; Lozano I; Muñoz-Aguilera R
Int J Cardiol; 2019 Jan; 274():163-169. PubMed ID: 30206014
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
Amara N; Boveda S; Defaye P; Klug D; Treguer F; Amet D; Perier MC; Gras D; Algalarrondo V; Bouzeman A; Piot O; Deharo JC; Fauchier L; Babuty D; Bordachar P; Sadoul N; Marijon E; Leclercq C;
Europace; 2018 Jan; 20(1):65-72. PubMed ID: 28082419
[TBL] [Abstract][Full Text] [Related]
19. Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic Cardiomyopathy.
van Velzen HG; Vriesendorp PA; Oldenburg RA; van Slegtenhorst MA; van der Velden J; Schinkel AFL; Michels M
Am J Cardiol; 2016 Sep; 118(6):881-887. PubMed ID: 27476098
[TBL] [Abstract][Full Text] [Related]
20. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy.
Landsberger M; Staudt A; Choudhury S; Trimpert C; Herda LR; Klingel K; Kandolf R; Schultheiss HP; Kroemer HK; Völker U; Felix SB
Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
